Actively Recruiting
Evaluating Safety and Effectiveness of the CellFX nsPFA Cardiac Catheter System for Treating Paroxysmal Atrial Fibrillation in Adults
Led by Pulse Biosciences, Inc. · Updated on 2026-05-06
215
Participants Needed
1
Research Sites
65 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and effectiveness of the CellFX nano-second Pulsed Field Ablation nsPFA Cardiac Catheter Ablation System for treating recurrent, drug-resistant, symptomatic paroxysmal atrial fibrillation AF. This prospective, multicenter, non-randomized clinical investigation focuses on patients with paroxysmal AF who require catheter ablation and have not responded well to medications. The study aims to assess outcomes primarily six months after the procedure using this novel device. Eligible participants undergo ablation using the CellFX nsPFA Cardiac Catheter System, which includes the nsPFA 360 Endocardial Ablation Catheter and related components. This system uses nonthermal nanosecond pulses of electrical energy to target cardiac tissue in a cell-specific manner, aiming to disrupt cells that contribute to arrhythmia. The treatment is delivered through an endocardial catheter during a cardiac electrophysiology procedure. The primary endpoints focus on safety and treatment success at 6 months post-ablation. Participants will be involved in the ablation procedure and followed for assessments of safety and efficacy at 7 days, 30 days, and 6 months after treatment. Researchers will monitor freedom from treatment failure and safety endpoints, as well as acute procedural success immediately post-ablation. Participants will undergo standard cardiac evaluation before the procedure and careful follow-up afterward to track outcomes and any adverse effects throughout the study period.
CONDITIONS
Brief Title
NS-PFA Catheter Ablation of Paroxysmal Atrial Fibrillation With the Pulse Biosciences CellFX System
Research Team
M
Micki Weisman
W
William A. Knape
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here